- Home
- IRS vs IOVA Comparison
IRS vs IOVA Comparison
Compare IRS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRS
- IOVA
- Stock Information
- Founded
- IRS 1943
- IOVA 2007
- Country
- IRS Argentina
- IOVA United States
- Employees
- IRS N/A
- IOVA N/A
- Industry
- IRS Homebuilding
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IRS Real Estate
- IOVA Health Care
- Exchange
- IRS Nasdaq
- IOVA Nasdaq
- Market Cap
- IRS 959.8M
- IOVA 975.1M
- IPO Year
- IRS 1994
- IOVA N/A
- Fundamental
- Price
- IRS $11.42
- IOVA $2.22
- Analyst Decision
- IRS
- IOVA Buy
- Analyst Count
- IRS 0
- IOVA 11
- Target Price
- IRS N/A
- IOVA $11.90
- AVG Volume (30 Days)
- IRS 299.3K
- IOVA 9.5M
- Earning Date
- IRS 11-05-2025
- IOVA 11-06-2025
- Dividend Yield
- IRS 8.20%
- IOVA N/A
- EPS Growth
- IRS N/A
- IOVA N/A
- EPS
- IRS 0.20
- IOVA N/A
- Revenue
- IRS $416,589,564.00
- IOVA $241,525,000.00
- Revenue This Year
- IRS N/A
- IOVA $67.40
- Revenue Next Year
- IRS N/A
- IOVA $56.32
- P/E Ratio
- IRS $5.52
- IOVA N/A
- Revenue Growth
- IRS N/A
- IOVA 636.99
- 52 Week Low
- IRS $10.61
- IOVA $1.64
- 52 Week High
- IRS $17.67
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- IRS 28.45
- IOVA 45.99
- Support Level
- IRS $11.75
- IOVA $2.19
- Resistance Level
- IRS $12.87
- IOVA $2.38
- Average True Range (ATR)
- IRS 0.78
- IOVA 0.14
- MACD
- IRS -0.20
- IOVA -0.01
- Stochastic Oscillator
- IRS 2.79
- IOVA 40.82
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.